Yes we have. But the ones that I’ve been involved with have had fundamental reasons why that has happened. (PTX- Cell therapies took a bath after one being trialed caused secondary cancer) (IMU- results were not meaningful and they went in new directions essentially starting from scratch)
CU6 has had nothing by positive results, trials are shorter and more numerous and the platform is less risky . I wouldn’t expect the CU6 chart to do an IMU, at least not from what we’ve seen so far. I’m still seeing this as a staircase chart with some recent over exuberance. I’m seeing some early signals of a turn around on the chart but nothing definitive. It seems like a good time to add a few more while everything is pretty quiet.
CU6 Price at posting:
$3.95 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)